• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

6,785
2,304
2,237
1,864
1,727

COUNTRY

1,033
871
272
254
210

CATEGORIES

  • 858
  • 186
  • 679
  • 1,127
  • 398
  • 270
  • 255
  • 66
  • 382
  • 725
  • 1,339
  • 1,356
  • 626
  • 884
  • 1,706
  • 2,689
  • 507
  • 732
  • 0
  • 93

PRICE

7,471
12,545
20,252
26,480

PUBLISHED

2,902
3,771
8,291
26,480

PRODUCT TYPE

21,606
2,901
872
827
164
44
21
21
17
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE
Drugs During Pregnancy and Lactation. Edition No. 3 Drugs During Pregnancy and Lactation. Edition No. 3 - Product Thumbnail Image

Drugs During Pregnancy and Lactation. Edition No. 3

Drugs During Pregnancy and Lactation, 3rd Edition is a quick and reliable reference for all those working in disciplines related to fertility, pregnancy, lactation, child health and human genetics who...

October 2014
Pharmacology of the Blood Brain Barrier: Targeting CNS Disorders, Vol 71 Pharmacology of the Blood Brain Barrier: Targeting CNS Disorders, Vol 71 - Product Thumbnail Image

Pharmacology of the Blood Brain Barrier: Targeting CNS Disorders, Vol 71

This new volume of Advances in Pharmacology presents pharmacology of the blood brain barrier, focusing on targeting CNS disorders. With a variety of chapters and the best authors in the field, the volume...

October 2014
Successful Medical Writing (Course, London) Successful Medical Writing (Course, London) - Product Thumbnail Image

Successful Medical Writing (Course, London)

The Successful Medical Writing course will be held on 30 September – 2 October 2014 at The Rembrandt Hotel, London Success in the pharmaceutical industry depends on the speed and efficiency of new drug...

September 2014

Advancing Access with Telehealth: Case Studies on Bridging Gaps in Care

From connecting Medicare beneficiaries in rural California to specialty care to facilitating dialogue among New York City teens with diabetes, telehealth is bridging gaps in healthcare access and quality...

September 2014
FROM
Clinical Research Week Advancing Partnerships, Innovation & Development in Clinical Trials Clinical Research Week Advancing Partnerships, Innovation & Development in Clinical Trials - Product Thumbnail Image

Clinical Research Week Advancing Partnerships, Innovation & Development in Clinical Trials

Conference Date: 24th - 26th, September, 2014 Venue: London, UK EVENT HIGHLIGHTS A practical conference focusing on operational, regulatory, contractual and quality concerns, this event will also have...

September 2014

Regulatory Affairs for Support Staff - An Overview of the Pharmaceutical Regulatory Affairs for Support Staff

24 & 25 September 2014 The Rembrandt Hotel, London INTRODUCTION This two day course provides an introduction to Regulatory Affairs and the basics of drug development and has been designed specifically...

September 2014
Veterinary Pharmacovigilance: Including an Update on Volume IXb - What you Need to Know to Comply (Course, London) Veterinary Pharmacovigilance: Including an Update on Volume IXb - What you Need to Know to Comply (Course, London) - Product Thumbnail Image

Veterinary Pharmacovigilance: Including an Update on Volume IXb - What you Need to Know to Comply (Course, London)

The Veterinary Pharmacovigilance course will take place on the 24 & 25 September 2014 at the Harrington Hall Hotel, London TOPICS TO BE ADDRESSED: - The Role of the Marketing Authorisation Holder -...

September 2014

United States Pharmaceuticals and Healthcare Report Q4 2014

BMI View: The US pharmaceutical market presents strong commercial opportunities across the industry. Total US pharmaceutical sales reached USD347.2bn in 2013 - more than three times the size of its...

September 2014

Ireland Pharmaceuticals and Healthcare Report Q4 2014

BMI View: The US government and the OECD recent proposals to discourage corporate inversion pose downside risk to the rate of M&A deals that opt to establish their new headquarters' domicile in Ireland, although...

September 2014

Slovenia Pharmaceuticals and Healthcare Report Q4 2014

BMI View: Slovenia is facing deflationary pressures on consumer prices, which will impact pharmaceutical spending - especially as an increasing proportion of high-value drugs is met by co-payments....

September 2014

Iran Pharmaceuticals and Healthcare Report Q4 2014

BMI View: BMI continues to adjust its forecasts for Iran's pharmaceutical market to account for the sanction-induced currency crisis and high rates of inflation. The rapid depreciation of the rial means...

September 2014

Kazakhstan Pharmaceuticals and Healthcare Report Q4 2014

BMI View: Kazakhstan's healthcare sector suffers from a lack of trained medical professionals and the inherent difficulties of providing infrastructure and access to healthcare in such a large country....

September 2014

Myanmar Pharmaceuticals and Healthcare Report Q4 2014

BMI View: While the current medical gap will attract some foreign investors into Myanmar, we highlight that the lack of basic infrastructure and political instability will potentially affect the growth...

September 2014

Bangladesh Pharmaceuticals and Healthcare Report Q4 2014

BMI View: We consider Bangladesh's commitment to another round of spending on the development of healthcare, information technology, infrastructure, energy production, education, agriculture and food...

September 2014

Austria Pharmaceuticals and Healthcare Report Q4 2014

BMI View: BMI has upwardly revised its pharmaceutical and healthcare forecasts for Austria, reflecting the country's improving economic prospects and attractiveness of these sectors in particular. The...

September 2014

Central America Pharmaceuticals and Healthcare Report Q4 2014

BMI View: Costa Rica and Panama will continue to outperform other Central American countries, namely El Salvador, Guatemala, Honduras, Nicaragua and Belize. The business-friendly environment, high percapita...

September 2014
Global and Chinese Alendronate Sodium Trihydrate Industry, 2009-2019 Market Research Report Global and Chinese Alendronate Sodium Trihydrate Industry, 2009-2019 Market Research Report - Product Thumbnail Image

Global and Chinese Alendronate Sodium Trihydrate Industry, 2009-2019 Market Research Report

The 'Global and Chinese Alendronate Sodium Trihydrate Industry, 2009-2019 Market Research Report' is a professional and in-depth study on the current state of the global Alendronate Sodium Trihydrate...

September 2014
FROM
Global and Chinese Antithrombin Alfa Industry, 2009-2019 Market Research Report Global and Chinese Antithrombin Alfa Industry, 2009-2019 Market Research Report - Product Thumbnail Image

Global and Chinese Antithrombin Alfa Industry, 2009-2019 Market Research Report

The 'Global and Chinese Antithrombin Alfa Industry, 2009-2019 Market Research Report' is a professional and in-depth study on the current state of the global Antithrombin Alfa industry with a focus...

September 2014
FROM
Global and Chinese N-(2,6-Dimethylphenl)-2-Piperidine Carboxamide (CAS 15883-20-2) Industry, 2009-2019 Market Research Report Global and Chinese N-(2,6-Dimethylphenl)-2-Piperidine Carboxamide (CAS 15883-20-2) Industry, 2009-2019 Market Research Report - Product Thumbnail Image

Global and Chinese N-(2,6-Dimethylphenl)-2-Piperidine Carboxamide (CAS 15883-20-2) Industry, 2009-2019 Market Research Report

The 'Global and Chinese N-(2,6-Dimethylphenl)-2-Piperidine Carboxamide Industry, 2009-2019 Market Research Report' is a professional and in-depth study on the current state of the global N-(2,6-Dimethylphenl)-2-Piperidine...

September 2014
FROM
Global and Chinese Imidazo-[1,2-b]Pyridazine (CAS 766-55-2) Industry, 2009-2019 Market Research Report Global and Chinese Imidazo-[1,2-b]Pyridazine (CAS 766-55-2) Industry, 2009-2019 Market Research Report - Product Thumbnail Image

Global and Chinese Imidazo-[1,2-b]Pyridazine (CAS 766-55-2) Industry, 2009-2019 Market Research Report

The 'Global and Chinese Imidazo-[1,2-b]Pyridazine Industry, 2009-2019 Market Research Report' is a professional and in-depth study on the current state of the global Imidazo-[1,2-b]Pyridazine industry...

September 2014
FROM
Loading Indicator

Our Clients

Our clients' logos